Steve Wubker New CEO of Mellitus Health

Steve Wubker is the new CEO of Mellitus Health effective July 27, 2020.

Steve Wubker brings decades of expertise to Mellitus Health. After a 15-year career in medical sales and medical sales management, in 2000 Steve became President and CEO of Transaction Data Systems (TDS), where he took its Rx30 Pharmacy software platform from roughly 800 pharmacies to an industry-leading 8,500 pharmacies.

“I am very excited to join the Mellitus Health team of professionals,” Steve said. “The opportunity to improve patient health outcomes through advanced software for diabetes control offers many parallels that drove our business at TDS—improved patient health, operational efficiencies, cost-effectiveness, and a tool that truly provides an invaluable asset for all parties involved. I see opportunities and challenges that remind me of when I first started at TDS, and I’m excited to start this familiar journey again with such a talented group of people. Knowing how dangerous and debilitating diabetes can be, I can’t wait to see the positive difference our team at Mellitus Health can make in the fight against diabetes.”

Steve has served as President of the American Pharmacy Alliance and Vice President of the American Society for the Automation of Pharmacy, and he has served on the advisory boards of RelayHealth, Change Healthcare, and Wolters Kluwer. He has also been a member of the National Community Pharmacy Association and the National Council for Prescription Drug Programs.

“Everyone at Mellitus Health is looking forward to the impact Steve’s proven leadership, pharmacy industry and sales experience, and vision will have on our company’s future,” said Josh Davidson, who has served as CEO of Mellitus Health since its founding, and will continue to serve in a leadership role as Chief Product Officer. “Our small team has accomplished a lot, and now we’ve come to this moment of opportunity. Steve has been here before, and he sees our technology’s enormous potential for improving diabetes care, especially now that pharmacy-based care and remote patient monitoring are more important than ever. He’s exactly the CEO we’ve been looking for to guide Mellitus Health through this exciting next chapter of our growth.”

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.